174 related articles for article (PubMed ID: 12450701)
21. Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection.
Flynn JN; Cannon CA; Neil JC; Jarrett O
J Virol; 1997 Oct; 71(10):7586-92. PubMed ID: 9311839
[TBL] [Abstract][Full Text] [Related]
22. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
[TBL] [Abstract][Full Text] [Related]
23. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.
Vahlenkamp TW; Tompkins MB; Tompkins WA
J Immunol; 2004 Apr; 172(8):4752-61. PubMed ID: 15067051
[TBL] [Abstract][Full Text] [Related]
24. Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats.
Li J; Brown WC; Song W; Carpino MR; Wolf AM; Grant CK; Elder JH; Collisson EW
Virus Res; 1995 Oct; 38(2-3):93-109. PubMed ID: 8578869
[TBL] [Abstract][Full Text] [Related]
25. Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.
Johnston RE; Johnson PR; Connell MJ; Montefiori DC; West A; Collier ML; Cecil C; Swanstrom R; Frelinger JA; Davis NL
Vaccine; 2005 Oct; 23(42):4969-79. PubMed ID: 16005121
[TBL] [Abstract][Full Text] [Related]
26. Perspectives on FIV vaccine development.
Elyar JS; Tellier MC; Soos JM; Yamamoto JK
Vaccine; 1997; 15(12-13):1437-44. PubMed ID: 9302758
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of vaccination strategies against infection with feline immunodeficiency virus (FIV) based on recombinant viral vectors expressing FIV Rev and OrfA.
Huisman W; Schrauwen EJ; Tijhaar E; Süzer Y; Pas SD; van Amerongen G; Sutter G; Rimmelzwaan GF; Osterhaus AD
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):332-8. PubMed ID: 18952300
[TBL] [Abstract][Full Text] [Related]
28. FIV vaccine studies. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets.
Hofmann-Lehmann R; Holznagel E; Aubert A; Bauer-Pham K; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):115-25. PubMed ID: 7618251
[TBL] [Abstract][Full Text] [Related]
29. Prior Puma Lentivirus Infection Modifies Early Immune Responses and Attenuates Feline Immunodeficiency Virus Infection in Cats.
Sprague WS; Troyer RM; Zheng X; Wood BA; Macmillian M; Carver S; VandeWoude S
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677149
[TBL] [Abstract][Full Text] [Related]
30. Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP Vaccine.
Sahay B; Aranyos AM; McAvoy A; Yamamoto JK
Methods Mol Biol; 2018; 1808():197-219. PubMed ID: 29956186
[TBL] [Abstract][Full Text] [Related]
31. Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.
Flynn JN; Cannon CA; Beatty JA; Mackett M; Rigby MA; Neil JC; Jarrett C
J Virol; 1994 Sep; 68(9):5835-44. PubMed ID: 8057464
[TBL] [Abstract][Full Text] [Related]
32. Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein.
Song W; Collisson EW; Li J; Wolf AM; Elder JH; Grant CK; Brown WC
Virology; 1995 Jun; 209(2):390-9. PubMed ID: 7778274
[TBL] [Abstract][Full Text] [Related]
33. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus.
Novotney C; English RV; Housman J; Davidson MG; Nasisse MP; Jeng CR; Davis WC; Tompkins MB
AIDS; 1990 Dec; 4(12):1213-8. PubMed ID: 1982410
[TBL] [Abstract][Full Text] [Related]
35. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
[TBL] [Abstract][Full Text] [Related]
36. Selective thymocyte depletion and immunoglobulin coating in the thymus of cats infected with feline immunodeficiency virus.
Orandle MS; Papadi GP; Bubenik LJ; Dailey CI; Johnson CM
AIDS Res Hum Retroviruses; 1997 May; 13(7):611-20. PubMed ID: 9135879
[TBL] [Abstract][Full Text] [Related]
37. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
Beatty JA; Willett BJ; Gault EA; Jarrett O
J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
[TBL] [Abstract][Full Text] [Related]
38. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC
Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854
[TBL] [Abstract][Full Text] [Related]
39. Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route.
Burkhard MJ; Mathiason CK; O'Halloran K; Hoover EA
AIDS Res Hum Retroviruses; 2002 Feb; 18(3):217-26. PubMed ID: 11839157
[TBL] [Abstract][Full Text] [Related]
40. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A
Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
